441 Results

People

  1. Hudis
    Hudis
  2. Bajorin
    Bajorin
  3. Seidman
    Seidman
  4. Zelenetz
    Zelenetz
  5. Aghajanian
    Aghajanian
  6. Fornier
    Fornier
  7. Norton
    Norton
  8. Tallman
    Tallman
  9. Hensley
    Hensley
  10. Moskowitz
    Moskowitz

Groups

  1. Department of Medicine (326)
  2. Solid Tumor Oncology Division (204)
  3. Hematologic Malignancies, Division of (144)
  4. Center for Hematologic Malignancies (128)
  5. Survivorship Research (93)
  6. Breast Medicine Service (63)
  7. Epidemiology and Biostatistics (59)
  8. Biostatistics Service (55)
  9. Lymphoma (54)
  10. Adult Leukemia (47)
  1. "febrile neutropenia"
Formats
  1. Journal Article (414)
  2. Review (15)
  3. Research Letter (7)
  4. Editorial (3)
  5. Conference Paper (1)
  6. Correspondence (1)
Groups
  1. Department of Medicine (326)
  2. Solid Tumor Oncology Division (204)
  3. Hematologic Malignancies, Division of (144)
  4. Center for Hematologic Malignancies (128)
  5. Survivorship Research (93)
  6. Breast Medicine Service (63)

More Groups

People
  1. Clifford Hudis (30)
  2. Dean Bajorin (21)
  3. Andrew Seidman (18)
  4. Andrew Zelenetz (17)
  5. Martin Tallman (17)
  6. Larry Norton (16)

More People

Years
  1. 2025 (10)
  2. 2024 (24)
  3. 2023 (26)
  4. 2022 (15)
  5. 2021 (11)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (52)
  2. Cancer (28)
  3. Blood (22)
  4. Annals of Oncology (18)
  5. Clinical Cancer Research (17)
  6. Leukemia and Lymphoma (15)

More Publications

Publishers
  1. Elsevier Inc. (54)
  2. American Society of Clinical Oncology (53)
  3. Wiley Blackwell (35)
  4. Springer (34)
  5. American Society of Hematology (30)
  6. Oxford University Press (30)

More Publishers

Results (441)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001
    Journal Article

    Abramson, J. S.; Palomba, M. L.; Gordon, L. I.; Lunning, M.; Wang, M.; Arnason, J.; Purev, E.; Maloney, D. G.; Andreadis, C.; Sehgal, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Sharon, E.; Park, S.; Ramaswamy, R.; Roe, C. E.; Irish, J. M.; Caldwell, A.; Wei, W.; Yacoub, A.; more...
    Annals of Hematology (2024)

    Fulltext@MSK | Save
  • Oncology for the rhinologist
    Review

    Tam, K.; Dunn, L. A.; Cohen, M. A.
    Current Opinion in Otolaryngology & Head and Neck Surgery (2024)

    Fulltext@MSK | Save
  • Rebuttal to comment on “concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer”
    Correspondence

    Han, J. E.; Zakeri, K.; Michel, L.; Sherman, E. J.; Lee, N. Y.
    Head & Neck (2024)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
    Research Letter

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G. T.; Romancik, J.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
    Journal Article

    Stein, E. M.; de Botton, S.; Cluzeau, T.; Pigneux, A.; Liesveld, J. L.; Cook, R. J.; Rousselot, P.; Rizzieri, D. A.; Braun, T.; Roboz, G. J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma
    Journal Article

    Fried, S.; Shkury, E.; Itzhaki, O.; Sdayoor, I.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Jacoby, E.; Shouval, R.; Kedmi, M.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled trial
    Editorial

    Hogan, C. A.; Miller, S.; Piantadosi, A.; Gaston, D. C.; Simner, P. J.; Nash, S.; Babady, N. E.
    Clinical Microbiology and Infection (2023)

    Fulltext@MSK | Save
  • Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution
    Review

    Santinelli, E.; Pascale, M. R.; Xie, Z.; Badar, T.; Stahl, M. F.; Bewersdorf, J. P.; Gurnari, C.; Zeidan, A. M.
    Blood Reviews (2023)

    Fulltext@MSK | Save
  • EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
    Journal Article

    Rosenberg, J. E.; Powles, T.; Sonpavde, G. P.; Loriot, Y.; Duran, I.; Lee, J. L.; Matsubara, N.; Vulsteke, C.; Castellano, D.; Mamtani, R.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save